Nifty Pharma Today: Index Gains 0.08% in Closing Bell

Closing Bell | 18 August 2026, 4:15 PM IST

Nifty Pharma closed marginally higher in a mixed session for its stocks. The index added 20.35 points, or 0.08%, to finish at 26,361.90. While the headline ended positive, the underlying breadth remained tilted towards declines, making stock selection an important part of the sector read.

Quick sector takeaways

• Nifty Pharma today ended at 26,361.90, up 20.35 points or 0.08% from the previous close of 26,341.55.
• The index moved between 26,341.35 and 26,527.85 during the session, finishing well below its intraday high.
• Of 20 display-safe stocks, 7 advanced and 13 declined, producing an advance-decline ratio of 0.54.
• Alkem Laboratories, Torrent Pharmaceuticals, Biocon and Divi’s Laboratories were among the leading gainers, while JB Chemicals & Pharmaceuticals, Gland Pharma and Zydus Lifesciences were notable laggards.

Nifty Pharma today: a modest positive close

Nifty Pharma today recorded a contained advance at the close, rising 0.08% over its previous close. The positive finish placed it among the session’s stronger configured sector indices, but the move was narrow rather than broadly shared across pharma stocks. The index opened at 26,352.95, slightly above the prior close, climbed to 26,527.85 during the day and then moderated to close at 26,361.90.

This sequence shows that the index preserved a small gain despite giving back a sizeable part of its intraday rise. The close was just 20.55 points above the day’s low of 26,341.35 and 165.95 points below the day high. That end-of-session position is an observation of the trading range, not a forecast of the next move.

Price snapshot

The 186.50-point intraday range highlights movement on both sides of the previous close. For the next session, readers can track whether the index sustains a position above its previous closing level and how it behaves within its fresh session range.

Sector ranking

Nifty Pharma was the second top gaining sector index among the configured sector indices on 18 August 2026. Nifty Auto led the positive group with a 0.30% rise, while Nifty Pharma followed with its 0.08% gain. This ranking is based on the day’s percentage move in the configured sector-index set, rather than an assessment of the entire equity market.

The ranking matters because it provides context for an otherwise small absolute move. On a day when several configured sector indices closed lower, pharma retained a positive close. However, the limited percentage advance and uneven constituent breadth call for a measured reading rather than a blanket sector-strength conclusion.

Constituent breadth

The sector’s 20 display-safe stocks showed mixed participation: 7 advanced, 13 declined and none were unchanged. The advance-decline ratio stood at 0.54. In simple terms, decliners outnumbered gainers even as the index finished in positive territory.

This divergence between index direction and breadth is central to the closing-bell picture. Positive moves in selected stocks were sufficient to keep the index above its previous close, while a larger number of stocks ended lower. Investors reviewing Nifty Pharma today may therefore separate the index result from the stock-by-stock distribution behind it.

Heavyweights versus broader participation

The named heavyweight set was mixed. Divi’s Laboratories gained 1.26% to ₹8,588, while Torrent Pharmaceuticals rose 1.45% to ₹4,971. In contrast, Sun Pharmaceutical Industries slipped 0.37% to ₹1,875.10, Cipla edged down 0.03% to ₹1,431.10, and Dr. Reddy’s Laboratories declined 1.11% to ₹1,178.80.

The supplied active-stock set also included Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Their mixed daily moves reinforce the broader pattern: positive contributions from some prominent names coexisted with declines in others. The sector close was positive, but participation was not uniform.

Key Nifty Pharma stocks

Biggest positive movers

Alkem Laboratories led the listed gainers, climbing 1.88% after opening at ₹5,374 and closing at ₹5,475. Torrent Pharmaceuticals added 1.45%, Biocon rose 1.33% to ₹417.50, Divi’s Laboratories gained 1.26%, and Aurobindo Pharma advanced 1.09% to ₹1,645. These gains provided the constructive elements in the sector’s close.

Several of these stocks ended below their respective day highs. Alkem Laboratories reached ₹5,510, Torrent Pharmaceuticals touched ₹5,009 and Divi’s Laboratories hit ₹8,630. The difference between closing prices and intraday highs simply reflects how these stocks finished relative to their own trading ranges.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to ₹2,408.90, after trading between ₹2,380 and ₹2,525.50. Gland Pharma lost 1.77% to ₹2,858.60, while Zydus Lifesciences declined 1.41% to ₹1,115.60 and ended at its day low. Abbott India, Lupin, Granules India and Dr. Reddy’s Laboratories also registered declines exceeding 1% or close to that mark.

The scale of JB Chemicals & Pharmaceuticals’ decline stood apart from the rest of the group. Alongside losses in several other pharma names, it explains why the sector’s breadth was negative despite the index’s modest green close.

Stocks to watch next session

• Alkem Laboratories: closed 1.88% higher at ₹5,475 after touching ₹5,510.
• Torrent Pharmaceuticals: ended 1.45% higher at ₹4,971, following a day high of ₹5,009.
• Divi’s Laboratories: finished up 1.26% at ₹8,588, below its ₹8,630 high.
• JB Chemicals & Pharmaceuticals: closed 3.87% lower at ₹2,408.90 after a broad intraday range.
• Gland Pharma: ended down 1.77% at ₹2,858.60.
• Zydus Lifesciences: finished 1.41% lower at ₹1,115.60, its day low.

The constructive case

The positive case rests on three observable points: Nifty Pharma closed above its previous close, it ranked as the second top gainer among configured sector indices, and selected key stocks delivered meaningful gains. Alkem Laboratories, Torrent Pharmaceuticals, Biocon, Divi’s Laboratories, Aurobindo Pharma, Natco Pharma and Laurus Labs were all higher on the day.

The index also opened above its previous close and held a positive closing result after testing higher levels during the session. That combination gives the sector a constructive, though restrained, end-of-session reading.

The cautious case

Caution comes from the breadth and the closing location within the day’s range. Thirteen of 20 display-safe stocks declined, compared with seven gainers. The index also closed much nearer its intraday low than its intraday high, after reaching 26,527.85 earlier in the day.

Losses were spread across several names, including JB Chemicals & Pharmaceuticals, Gland Pharma, Zydus Lifesciences, Abbott India, Lupin, Granules India and Dr. Reddy’s Laboratories. The 0.08% index gain therefore does not indicate broad-based participation across the sector.

Univest Insights

The closing setup for Nifty Pharma today is best described as positive at the index level but mixed beneath the surface. The 20.35-point rise kept the sector in the green and placed it second among the configured gainers, yet negative breadth tempered the overall strength of that result.

The day’s range offers useful context. After opening at 26,352.95, the index pushed to 26,527.85 before closing at 26,361.90. This showed an early-to-intraday expansion followed by moderation, with the final level only modestly above the previous close.

At the stock level, gains in Alkem Laboratories, Torrent Pharmaceuticals and Divi’s Laboratories contrasted with notable falls in JB Chemicals & Pharmaceuticals and Gland Pharma. This makes individual price action as relevant as the sector headline for readers following pharma shares.

For a wider market context alongside this sector-specific wrap, visit Univest Market View. For traders and investors, the key signal to watch is…

Published on 18 August 2026 at 4:17 PM IST

Frequently asked questions

What was Nifty Pharma today?

Nifty Pharma closed at 26,361.90 on 18 August 2026, up 20.35 points or 0.08% from 26,341.55.

What were Nifty Pharma’s day high and day low?

The index recorded a day high of 26,527.85 and a day low of 26,341.35.

Why was Nifty Pharma the second top gainer?

Its 0.08% gain was the second-highest positive percentage move among the configured sector indices, behind Nifty Auto’s 0.30% rise.

How was the breadth within Nifty Pharma?

Among 20 display-safe stocks, 7 advanced and 13 declined, with no unchanged stocks.

Which stocks were the top gainers in Nifty Pharma?

Alkem Laboratories, Torrent Pharmaceuticals, Biocon, Divi’s Laboratories and Aurobindo Pharma were the five listed top gainers.

Which stock fell the most in Nifty Pharma?

JB Chemicals & Pharmaceuticals was the largest listed loser, declining 3.87% to ₹2,408.90.